Pharmacological interventions for AD that target the cholinergic system [10] modulate neurogenic mechanisms via cAMP response element-binding protein (CREB) and/or brain-derived neurotrophic factor (BDNF)-related pathways [8]. This evidence concerns the gene BDNF and Alzheimer disease.